-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OrAU5VbfHZU+Wn7S/AH1SymPAa7i/F3YzJwulAVBvC8BSUbie5gZ4L2D9f4Yqk+B 0KzmVFniK2UCfeOxOfdfVA== 0001324517-07-000027.txt : 20070418 0001324517-07-000027.hdr.sgml : 20070418 20070418181156 ACCESSION NUMBER: 0001324517-07-000027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070416 FILED AS OF DATE: 20070418 DATE AS OF CHANGE: 20070418 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 CHIPETA WAY STE 240 CITY: SALT LAKE CITY STATE: UT ZIP: 84108-1256 BUSINESS PHONE: 8015834939 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COLES N ANTHONY CENTRAL INDEX KEY: 0001197018 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 07774461 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-04-16 0000890465 NPS PHARMACEUTICALS INC NPSP 0001197018 COLES N ANTHONY 383 COLOROW DRIVE SALT LAKE CITY UT 84108 1 1 0 0 CEO, President and Director Common Stock 2007-01-31 4 J 0 7780 3.22 A 7780 D Stock Option 4.31 2007-04-16 4 A 0 22500 0 A 2008-04-16 2017-04-16 Common Stock 22500 22500 D Granted under the 2005 Omnibus Incentive Plan. The option becomes exercisable based on the following four-year vesting schedule: 28% on the first anniversary of the grant, and 2% each month thereafter. Purchase of shares under the Company's 1994 Employee Stock Purchase Plan. Val R. Antczak 2007-04-18 -----END PRIVACY-ENHANCED MESSAGE-----